(Date:11/18/2009)..., NEW YORK, Nov. 18 Reportlinker...s available in its catalogue. ,, Biotechnolog... http://www.reportlinker.com/p0164375/Biotechnolog...source=prnewswire&utm_medium=pr&utm_campai...gy are complex chemical compounds used in a range ...
(Date:11/18/2009)... Promega Corporation and SwitchGear G... DNA-protein interactions. , ...Promega Corporation and SwitchGear Genomics announ...nteractions. Results of a study using the HaloCHIP... demonstrate the ability to correlate DNA binding ...
(Date:11/18/2009)...VT-111 significantly reduces key cardiac enzymes a... presented at American Heart Association 2009 Scie...wire/ - Viron Therapeutics Inc., a biotechnology c...ting protein therapeutics derived from pathogens, ...rial evaluating VT-111 (Serp-1), an anti-inflammat...
(Date:11/18/2009)..., BALTIMORE, Nov. 18 Ch...CSBR), an oncology drug development company with a...ting the development and enhancing the value of on...ng agreement with Yale University and Southern Res...or cancer treatment. Scientists from Yale and Sou...
Breaking Biology Technology:Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4...t microRNA-based Diagnostic Tests are Expected to ...Nanogen,s MGB Probe Technology, Rosetta Genomics ...igned, Real-Time PCR Diagnostic Assays That Allo...on of microRNA in Tissues and Body Fluids, REHOVO...1, Rosetta Genomics, Ltd. (NASDQ: ROSG) announced,...
...YORK, Dec. 10 /Xinhua-PRNewswire-FirstCall/ -- Chi...rd: CYIG; hereinafter the,"Company") announced tod...o. Ltd. ("Shandong YCT"), the Company,s wholly-own...a, has been awarded the honor of China,s "Top 100,...euticals sector. The,award was conferred by the Sm...
...ON, Dec. 10 Oxford Finance Corporation and GE,Hea...ounds Sterling 7.5,million senior secured loan to ... the largest venture loans provided to a biotechno...d in Cambridge, England, is one of the largest,pri...ting on the discovery,and development of small mol...
Other Biology Technology:Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 2Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 3Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology 4CYIG Awarded China's "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "'Torch Plan' Key High-Tech Enterprise" 2Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe 2... heart cells in culture to mimic the properties of...t into the mechanisms that spawn irregular heart r...evealed that while electric shocks such as those d...t waves, in some cases they cause them to accelera...opkins University team, led by Nenad Bursac of Duk...
...spectrometry for decades to determine the chemical...d to identify viruses, and never in complex enviro...ns Bloomberg School of Public Health recently demo...potential to be applied for this purpose. Using a ...ed, purified and concentrated a norovirus surrogat...
..., formerly a Senior Research Associate at the Stow...urquié, Ph.D., Stowers Institute Investigator and ...titute, have demonstrated that the long-studied fa...essed in a cyclic fashion during the formation of ...bryo. , The findings, which were published in the...
Other Biology News:Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 2Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 3Researchers use mass spectrometry to detect norovirus particles 2Stowers scientists demonstrate mechanism of vertebral formation 2Mouse Anti-Human PPP2R2C Monoclonal Antibody, Unconjugated, Clone 6D1 from Novus Biologicals
96-well 0.2 ml PCR Plate Caps, 300 from Bio-Rad
PROTEIN G PLUS AGAROSE from Pierce Biotechnology, Inc.
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: